Bulls maintain their grip for the third week in a row

Transcription

1 Weekly Commentary Market Snap 17 th November BROKING INVESTMENT BANKING RESEARCH DISTRIBUTION DEPOSITORY Index Previous Close Open High Low Close Change Change% Sensex 35, , , , , Nifty 10, , , , , Bulls maintain their grip for the third week in a row Indian equity benchmark ended on a positive note in the week ended 17 th November, 2018 after trading in green. Key indices were positive in three out of five sessions of the week. The S&P BSE Sensex gained points or 0.85% to settle at 35, in the week ended 16 th November The CNX Nifty gained points or 0.92% to settle at 10, The BSE Mid Cap index gained points or 0.36% to settle at 14, The BSE Small Cap index lost points or 1.27% to settle at 14, Week started on a pessimistic note on Monday, 12 th November 2018; Sensex lost points or 0.98% to settle at 34,812.99; Benchmark Indices struggled in the first leg of the trade after an overnight sell off on wall street on Tuesday s 13 th November 2018 trade. However, recovery in Asian markets helped domestic markets recover and end in green. Sensex gained points or 0.95% to settle at 35, On Wednesday, 14 th November2018, markets tossed between bullish and bearish arena to end on a flat note. Sensex lost 2.50 points or 0.01% to settle at 35, Thursday, 15 h November 2018 the weekly expiry of Bank Nifty, markets made a volatile start but ended in green; Sensex gained points or 0.34% to settle at 35, On Friday, 16 th November 2018 the volatile day of trade ended marginally in green. S&P BSE Sensex gained points or 0.56% to settle at 35, FMCG Sector VADILALIND JUBLFOOD TATAGLOBAL DABUR GODREJCP NESTLEIND UBL COLPAL BRITANNIA The S&P FMCG ended at 11, up by points or by 1.15%. Vadilal Industries, Jubilant Foods, Tata Global and Dabur were among the major gainers in the week gaining 14%-04%. Most active (by value) Rs. Cr (NSE) Name Qty Pr. Vol. JETAIRWAYS ASHOKLEY DHFL PCJEWELLER JUBLFOOD Most active (by Qty) Rs. Cr (NSE) Name Qty Pr. Vol. INFIBEAM IDEA PCJEWELLER ASHOKLEY RCOM Top gainers (NSE) Name Current Pr. Prev. Pr. %change JETAIRWAYS ARIHANT KMILES POKARNA ADANITRANS Top losers (NSE) Name Current Pr. Prev. Pr. %change VETO AIFL SHANKARA PCJEWELLER INFIBEAM For Private Circulation Only 1 Hem Research

2 Consumer Durables TITAN VIPIND BAJAJELEC SYMPHONY VIDEOIND RAJESHEXPO TTKPRESTIG WHIRLPOOL PCJEWELLER The S&P Consumer Durables Index ended at 20, up by points or by 3.15%. Titan, VIP Industries, Bajaj Electricals and Symphony were among the major gainers in the week gaining 09%-00%. Bank Sector BANKBARODA ICICIBANK KOTAKBANK SBIN HDFCBANK PNB AXISBANK INDUSINDBK FEDERALBNK The S&P Bank index ended at 29, up by points or by 1.45%.Bank of Baroda, ICICI Bank, Kotak Bank and SBI were among the major gainers in the week gaining by 04%-02% For Private Circulation Only 2 Hem Research

3 Corporate News: CESC has reported 9.72% rise in its net profit at Rs 271 crore for the quarter under review as compared to Rs 247 crore for the same quarter in the previous year. Total income of the company increased by 5.89% at Rs 2,248 crore for Q2FY19 as compared Rs 2,123 crore for the corresponding quarter previous year. TTK Healthcare has entered into an agreement with i-health, lnc., USA, for distribution of their health and wellness products in India. SREI Infrastructure Finance has reported a rise of 7.61% in its net profit at Rs crore for the quarter under review as compared to Rs crore for the same quarter in the previous year. However, total income of the company decreased by 1.76% at Rs crore for Q2FY19 as compared Rs crore for the corresponding quarter previous year. Pfizer has reported 13.81% fall in its net profit at Rs crore for the quarter under review as compared to Rs crore for the same quarter in the previous year. Total income of the company decreased by 6.39% at Rs crore for Q2FY19 as compared Rs crore for the corresponding quarter previous year. Wheels India has reported 14.16% fall in its net profit at Rs crore for the quarter under review as compared to Rs crore for the same quarter in the previous year. However, total income of the company increased by 32.73% at Rs crore for Q2FY19 as compared Rs crore for the corresponding quarter previous year. Ipca Laboratories has reported 24.12% rise in its net profit at Rs crore for the quarter under review as compared to Rs crore for the same quarter in the previous year. Total income of the company increased by 15.57% at Rs 1, crore for Q2FY19 as compared Rs crore for the corresponding quarter previous year. Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Abacavir and Lamivudine Tablets USP, 600 mg/300 mg (US RLD- EPZICOM), and Fondaparinux Sodium Injection USP, 2.5 mg/0.5 ml, 5 mg/0.4 ml 7.5 mg/0.6 ml and 10 mg/0.8 ml single-dose (US RLD- ARIXTRA). Welspun Corp has been awarded a large order for India, from one of its very prestigious clients in North America for supply of 166 KMT of Pipes for an oil & gas project. Additionally, the company has also received orders in Oil & Gas and Water sectors in India. With this, the company's current order book stands at 1,851 KMTs valued at Rs 166 billion. UPL has signed pact with Norway-based consulting firm Gexcon AS for setting up of a Centre of Excellence (CoE) in the state of Gujarat, which will focus on research activities to help estimate and mitigate industrial accidents. Shah Alloys has reported net profit of Rs crore for the quarter under review against net loss Rs 3.59 crore for the same quarter in the previous year. Total income of the company increased by 28.30% at Rs crore for Q2FY19 as compared Rs crore for the corresponding quarter previous year. Shilpa Medicare has decided to acquire 5.22% stake in Prathijna Sustainable solutions. EPC Industries has incorporated a new subsidiary company namely Mahindra Top Greenhouse (MTGPL). MIGPL will provide solutions to Protected Cultivation Technology Products in Agriculture. It will also strengthen the company's position in Agri technology. For Private Circulation Only 3 Hem Research

4 HEM SECURITIES LIMITED MEMBER-BSE,CDSL, SEBI REGISTERED CATEGORY I MERCHANT BANKER Sebi Registration No For Research Analyst: INH MUMBAI OFFICE: 904, A WING, 9 FLOOR, NAMAN MIDTOWN, SENAPATI BAPAT MARG, PRABHADEVI STATION, LOWER PAREL, MUMBAI PHONE JAIPUR OFFICE:: , JAIPUR TOWERS, M I ROAD, JAIPUR PHONE GROUP COMPANIES HEM FINLEASE PRIVATE LIMITED MEMBER-NSE HEM MULTI COMMODITIES PRIVATE LIMITED MEMBER-NCDEX, MCX HEM FINANCIAL SERVICES LIMITED NBFC REGISTERED WITH RBI For Private Circulation Only 4 Hem Research

5 Disclaimer & Disclosure: This document is prepared for our clients only, on the basis of publicly available infor- mation and other sources believed to be reliable. Whilst we are not soliciting any action based on this information, all care has been taken to ensure that the facts are accurate, fair and reasonable. This information is not intended as an offer or solicitation for the purchase or sell of any financial instrument and at any point should not be considered as an investment advise. Reader is requested to rely on his own decision and may take independent professional ad- vise before investing. Hem Securities Limited, Hem Finlease Private Limited, Hem Multi Commodities Pvt. Limited, Directors and any of its employees shall not be responsible for the content. The person accessing this information specifically agrees to exempt Hem Securities Limited, Hem Finlease Private Limited, Hem Multi Commodities Pvt. Limited or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and further agrees to hold Hem Securities Limited, Hem Finlease Private Limited, Hem Multi Commodities Pvt. Limited or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The companies and its affiliates, officers, directors, and employees, including persons involved in the preparation or issuance of this material may from time to time, have long or short positions in, and buy or sell the securities there of, company (ies) mentioned here in and the same have acted upon or used the information prior to, or immediately following thepublication. Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirect- ly related to the specific recommendations and views expressed by research analyst(s) in this report. For Private Circulation Only 5 Hem Research